Your Trusted Brand for Over 35 Years

Life Extension Magazine

<< Back to September 2012

A Deadly Waiting Game

September 2012

By William Faloon


1. Available at: Accessed May 15, 2012.

2. Sellers MB, Newby LK. Atrial fibrillation, anticoagulation, fall risk, and outcomes in elderly patients. Am Heart J. 2011 Feb;161(2):241-6.

3. Available at: Accessed May 8, 2012.

4. Tamargo J, Caballero R, Delpón E. Pharmacological approaches in the treatment of atrial fibrillation. Curr Med Chem. 2004 Jan;11(1):13-28.

5. Naccarelli GV, Wolbrette DL, Khan M, et al. Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials. Am J Cardiol. 2003 Mar 20;91(6A):15D-26D.

6. Scott PJ. Anticoagulant drugs in the elderly: the risks usually outweigh the benefits. BMJ. 1988 Nov 12;297(6658):1261-63.

7. Available at: Accessed May 15, 2012.

8. Zak J. Ablation to treat atrial fibrillation: beyond rhythm control. Crit Care Nurse. 2010 Dec;30(6):68-79.

9. Thamilarasan M, Klein AL. Transesophageal echocardiography (TEE) in atrial fibrillation. Cardiol Clin. 2000 Nov;18(4):819-31.

10. Institute of Medicine Committee on the Future of Emergency Care in the United States Health System. Hospital-based emergency care: at the breaking point. Washington, DC: National Academies Press, 2006.

11. Hospital emergency departments: crowding continues to occur, and some patients wait longer than recommended time frames. Washington, DC: Government Accountability Office, 2009. (GAO-09-347.)

12. Hospital emergency departments: crowded conditions vary among hospitals and communities. Washington, DC: General Accounting Office, 2003. (GAO-03-460.)

13. Available at: emergcarecrisis.pdf. Accessed May 16, 2012.

14. Bernstein SL, Aronsky D, Duseja R, et al. Society for Academic Emergency Medicine, Emergency Department Crowding Task Force. The effect of emergency department crowding on clinically oriented outcomes. Acad Emerg Med. 2009 Jan;16(1):1-10.

15. Wallentin L, Yusuf S, Ezekowitz MD, et al.; RE-LY investigators. Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial. Lancet. 2010 Sep 18;376(9745):975-83.

16. Available at: Accessed May 16, 2012.

17. Available at: Accessed May 16, 2012.

18. Available at: Accessed May 16, 2012.

19. Mosley WJ 2nd, Lloyd-Jones DM. Epidemiology of hypertension in the elderly. Clin Geriatr Med. 2009 May;25(2):179-89.

20. Lloyd-Jones DM, Evans JC, Levy D. Hypertension in adults across the age spectrum: current outcomes and control in the community. JAMA. 2005 Jul 27;294(4):466-72.

21. Kshirsagar AV, Carpenter M, Bang H, Wyatt SB, Colindres RE. Blood pressure usually considered normal is associated with an elevated risk of cardiovascular disease. Am J Med. 2006 Feb;119(2):133-41.

22. Hyman DJ, Pavlik VN. Poor hypertension control: let's stop blaming the patients. Cleve Clin J Med. 2002 Oct;69(10):793-9.

23. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R; Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002 Dec 14;360(9349):1903-13.

24. Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. hypertension. JAMA. 2003 Dec;42(6):1206-52.

25. Uchino K, Hernandez AV. Dabigatran association with higher risk of acute coronary events: meta-analysis of noninferiority randomized controlled trials. Arch Intern Med. 2012 Mar 12;172(5):397-402.